Anticipate some write-downs of inventory as they spend the next 12 - 18 months trying to reduce the aging inventory. The majority of the write-downs wont appear in the next set of financials though so further joy to be had next financial year (possibly in the 2017/2018 1H year results) if they are still around.
I wonder if all the margin calls have been called in and settled yet and the ASX200 has a March review and it will be interesting to see if survives that one, if not it will trigger some more selling down. Not to mention the shorting market and whatever that lot are up to.
Young Mr Cohen certainly has his work cut out for him from an operational, market credibility perspective and the Chair has his work cut out for him with shareholder engagement, ASIC inquiry, possible Class Actions and some angry ants wanting to replace over his Board.
BAL Price at posting:
$4.13 Sentiment: None Disclosure: Not Held
